Role of Rab GTPases in Hepatocellular Carcinoma

References

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492
   PubMed Web of Science ®Google Scholar
• Dong ZR, Zhou W, Sun D, et al. Role of the E3 ubiquitin ligase TRIM4 in predicting the prognosis of hepatocellular carcinoma. J Cancer. 2020;11(14):4007–4014. doi:10.7150/jca.37164
   Web of Science ®Google Scholar
• Balogh J, Victor D 3rd, Asham EH, et al. Hepatocellular carcinoma: a review. J Hepatocell Carcinoma. 2016;3:41–53. doi:10.2147/JHC.S61146
   PubMed Web of Science ®Google Scholar
• Dong ZR, Sun D, Yang YF, et al. TMPRSS4 drives angiogenesis in hepatocellular carcinoma by promoting HB-EGF expression and proteolytic cleavage. Hepatology. 2020;72(3):923–939. doi:10.1002/hep.31076
   Web of Science ®Google Scholar
• Dong XF, Liu TQ, Zhi XT, et al. COX-2/PGE2 axis regulates HIF2α activity to promote hepatocellular carcinoma hypoxic response and reduce the sensitivity of sorafenib treatment. Clin Cancer Res. 2018;24(13):3204–3216. doi:10.1158/1078-0432.CCR-17-2725
   PubMed Web of Science ®Google Scholar
• Yim SY, Lee JS. An overview of the genomic characterization of hepatocellular carcinoma. J Hepatocell Carcinoma. 2021;8:1077–1088. doi:10.2147/JHC.S270533
   Web of Science ®Google Scholar
• Stenmark H. Rab GTPases as coordinators of vesicle traffic. Nat Rev Mol Cell Biol. 2009;10(8):513–525. doi:10.1038/nrm2728
   PubMed Web of Science ®Google Scholar
• Recchi C, Seabra MC. Novel functions for Rab GTPases in multiple aspects of tumour progression. Biochem Soc Trans. 2012;40(6):1398–1403. doi:10.1042/BST20120199
   Web of Science ®Google Scholar
• Müller MP, Goody RS. Molecular control of Rab activity by GEFs, GAPs and GDI. Small GTPases. 2018;9(1–2):5–21. doi:10.1080/21541248.2016.1276999
   PubMedGoogle Scholar
• Pylypenko O, Hammich H, Yu IM, Houdusse A. Rab GTPases and their interacting protein partners: structural insights into Rab functional diversity. Small GTPases. 2018;9(1–2):22–48. doi:10.1080/21541248.2017.1336191
   PubMedGoogle Scholar
• Barr F, Lambright DG. Rab GEFs and GAPs. Curr Opin Cell Biol. 2010;22(4):461–470. doi:10.1016/j.ceb.2010.04.007
   PubMed Web of Science ®Google Scholar
• Zhang FL, Casey PJ. Protein prenylation: molecular mechanisms and functional consequences. Annu Rev Biochem. 1996;65:241–269. doi:10.1146/annurev.bi.65.070196.001325
   PubMed Web of Science ®Google Scholar
• Wu YW, Tan KT, Waldmann H, Goody RS, Alexandrov K. Interaction analysis of prenylated Rab GTPase with Rab escort protein and GDP dissociation inhibitor explains the need for both regulators. Proc Natl Acad Sci U S A. 2007;104(30):12294–12299. doi:10.1073/pnas.0701817104
   Web of Science ®Google Scholar
• Gillingham AK, Sinka R, Torres IL, Lilley KS, Munro S. Toward a comprehensive map of the effectors of rab GTPases. Dev Cell. 2014;31(3):358–373. doi:10.1016/j.devcel.2014.10.007
   PubMed Web of Science ®Google Scholar
• Boulay PL, Mitchell L, Turpin J, et al. Rab11-FIP1C is a critical negative regulator in ErbB2-mediated mammary tumor progression. Cancer Res. 2016;76(9):2662–2674. doi:10.1158/0008-5472.CAN-15-2782
   Web of Science ®Google Scholar
• Feng G, Qin L, Liao Z, et al. Knockdown Rab11-FIP2 inhibits migration and invasion of nasopharyngeal carcinoma via suppressing Rho GTPase signaling. J Cell Biochem. 2020;121(2):1072–1086. doi:10.1002/jcb.29344
   Web of Science ®Google Scholar
• Yun UJ, Sung JY, Park SY, et al. Oncogenic role of rab escort protein 1 through EGFR and STAT3 pathway. Cell Death Dis. 2017;8(2):e2621. doi:10.1038/cddis.2017.50
   Web of Science ®Google Scholar
• Chen TW, Yin FF, Yuan YM, et al. CHML promotes liver cancer metastasis by facilitating Rab14 recycle. Nat Commun. 2019;10(1):2510. doi:10.1038/s41467-019-10364-0
   Web of Science ®Google Scholar
• Zhang W, Cao L, Liu X, et al. High expression of CHML predicts poor prognosis of multiple myeloma. J Cancer. 2019;10(24):6048–6056. doi:10.7150/jca.34465
   Web of Science ®Google Scholar
• Pellinen T, Arjonen A, Vuoriluoto K, Kallio K, Fransen JA, Ivaska J. Small GTPase Rab21 regulates cell adhesion and controls endosomal traffic of beta1-integrins. J Cell Biol. 2006;173(5):767–780. doi:10.1083/jcb.200509019
   PubMed Web of Science ®Google Scholar
• Mitra S, Cheng KW, Mills GB. Rab GTPases implicated in inherited and acquired disorders. Semin Cell Dev Biol. 2011;22(1):57–68. doi:10.1016/j.semcdb.2010.12.005
   PubMed Web of Science ®Google Scholar
• White E, Mehnert JM, Chan CS. Autophagy, metabolism, and cancer. Clin Cancer Res. 2015;21(22):5037–5046. doi:10.1158/1078-0432.CCR-15-0490
   PubMed Web of Science ®Google Scholar
• Akkoç Y, Gözüaçık D. Autophagy and liver cancer. Turk J Gastroenterol. 2018;29(3):270–282. doi:10.5152/tjg.2018.150318
   PubMed Web of Science ®Google Scholar
• Takats S, Boda A, Csizmadia T, Juhasz G. Small GTPases controlling autophagy-related membrane traffic in yeast and metazoans. Small GTPases. 2018;9(6):465–471. doi:10.1080/21541248.2016.1258444
   PubMedGoogle Scholar
• Lu Q, Wang PS, Yang L. Golgi-associated Rab GTPases implicated in autophagy. Cell Biosci. 2021;11(1):35. doi:10.1186/s13578-021-00543-2
   Web of Science ®Google Scholar
• Zhu Y, Wang R, Chen W, Chen Q, Zhou J. Construction of a prognosis-predicting model based on autophagy-related genes for hepatocellular carcinoma (HCC) patients. Aging. 2020;12(14):14582–14592. doi:10.18632/aging.103507
   Google Scholar
• Wallings RL, Tansey MG. LRRK2 regulation of immune-pathways and inflammatory disease. Biochem Soc Trans. 2019;47(6):1581–1595. doi:10.1042/BST20180463
   PubMed Web of Science ®Google Scholar
• Patrussi L, Baldari CT. The Rab GTPase Rab8 as a shared regulator of ciliogenesis and immune synapse assembly: from a conserved pathway to diverse cellular structures. Small GTPases. 2016;7(1):16–20. doi:10.1080/21541248.2015.1111852
   PubMedGoogle Scholar
• Peinado H, Alecˇković M, Lavotshkin S, et al. Corrigendum: melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med. 2016;22(12):1502. doi:10.1038/nm1216-1502b
   PubMed Web of Science ®Google Scholar
• Muralidharan-Chari V, Clancy J, Plou C, et al. ARF6-regulated shedding of tumor cell-derived plasma membrane microvesicles. Curr Biol. 2009;19(22):1875–1885. doi:10.1016/j.cub.2009.09.059
   PubMed Web of Science ®Google Scholar
• Yu X, Prekeris R, Gould GW. Role of endosomal Rab GTPases in cytokinesis. Eur J Cell Biol. 2007;86(1):25–35. doi:10.1016/j.ejcb.2006.10.002
   PubMed Web of Science ®Google Scholar
• Blanc L, Vidal M. New insights into the function of Rab GTPases in the context of exosomal secretion. Small GTPases. 2017;9(1–2):95–106. doi:10.1080/21541248.2016.1264352
   Google Scholar
• Chen L, Guo P, He Y, et al. HCC-derived exosomes elicit HCC progression and recurrence by epithelial-mesenchymal transition through MAPK/ERK signalling pathway. Cell Death Dis. 2018;9(5):513. doi:10.1038/s41419-018-0534-9
   PubMed Web of Science ®Google Scholar
• Yang JD, Hainaut P, Gores GJ, Amadou A, Plymoth A, Roberts LR. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol. 2019;16(10):589–604. doi:10.1038/s41575-019-0186-y
   PubMed Web of Science ®Google Scholar
• Ng SA, Lee C. Hepatitis B virus X gene and hepatocarcinogenesis. J Gastroenterol. 2011;46(8):974–990. doi:10.1007/s00535-011-0415-9
   PubMed Web of Science ®Google Scholar
• Sheng Y, Li J, Zou C, et al. Downregulation of miR-101-3p by hepatitis B virus promotes proliferation and migration of hepatocellular carcinoma cells by targeting Rab5a. Arch Virol. 2014;159(9):2397–2410. doi:10.1007/s00705-014-2084-5
   Web of Science ®Google Scholar
• You X, Liu F, Zhang T, Li Y, Ye L, Zhang X. Hepatitis B virus X protein upregulates oncogene Rab18 to result in the dysregulation of lipogenesis and proliferation of hepatoma cells. Carcinogenesis. 2013;34(7):1644–1652. doi:10.1093/carcin/bgt089
   PubMed Web of Science ®Google Scholar
• Macovei A, Petrareanu C, Lazar C, Florian P, Branza-Nichita N. Regulation of hepatitis B virus infection by Rab5, Rab7, and the endolysosomal compartment. J Virol. 2013;87(11):6415–6427. doi:10.1128/JVI.00393-13
   PubMed Web of Science ®Google Scholar
• Zhou T, Jin M, Ding Y, et al. Hepatitis B virus dampens autophagy maturation via negative regulation of Rab7 expression. Biosci Trends. 2016;10(4):244–250. doi:10.5582/bst.2016.01049
   PubMed Web of Science ®Google Scholar
• Bartusch C, Döring T, Prange R. Rab33B controls hepatitis B virus assembly by regulating core membrane association and nucleocapsid processing. Viruses. 2017;9(6):157. doi:10.3390/v9060157
   Web of Science ®Google Scholar
• Takeda M, Ikeda M, Satoh S, Dansako H, Wakita T, Kato N. Rab13 is involved in the entry step of hepatitis C virus infection. Acta Med Okayama. 2016;70(2):111–118.
   Web of Science ®Google Scholar
• Manna D, Aligo J, Xu C, et al. Endocytic Rab proteins are required for hepatitis C virus replication complex formation. Virology. 2010;398(1):21–37. doi:10.1016/j.virol.2009.11.034
   Web of Science ®Google Scholar
• Elgner F, Hildt E, Bender D. Relevance of Rab proteins for the life cycle of hepatitis C virus. Front Cell Dev Biol. 2018;6:166. doi:10.3389/fcell.2018.00166
   PubMed Web of Science ®Google Scholar
• Dansako H, Hiramoto H, Ikeda M, Wakita T, Kato N. Rab18 is required for viral assembly of hepatitis C virus through trafficking of the core protein to lipid droplets. Virology. 2014;462–463:166–174. doi:10.1016/j.virol.2014.05.017
   PubMed Web of Science ®Google Scholar
• Salloum S, Wang H, Ferguson C, Parton RG, Tai AW. Rab18 binds to hepatitis C virus NS5A and promotes interaction between sites of viral replication and lipid droplets. PLoS Pathog. 2013;9(8):e1003513. doi:10.1371/journal.ppat.1003513
   PubMed Web of Science ®Google Scholar
• Pham TM, Tran SC, Lim YS, Hwang SB. Hepatitis C virus-induced Rab32 aggregation and its implications for virion assembly. J Virol. 2017;91(3):e01662–16. doi:10.1128/JVI.01662-16
   Web of Science ®Google Scholar
• Tsuruta F, Masuyama N, Gotoh Y. The phosphatidylinositol 3-kinase (PI3K)-Akt pathway suppresses Bax translocation to mitochondria. J Biol Chem. 2002;277(16):14040–14047. doi:10.1074/jbc.M108975200
   PubMed Web of Science ®Google Scholar
• Von Thun A, Birtwistle M, Kalna G, et al. ERK2 drives tumour cell migration in three-dimensional microenvironments by suppressing expression of Rab17 and liprin-beta2. J Cell Sci. 2012;125(Pt 6):1465–1477.
   PubMed Web of Science ®Google Scholar
• Wang K, Mao Z, Liu L, et al. Rab17 inhibits the tumourigenic properties of hepatocellular carcinomas via the Erk pathway. Tumour Biol. 2015;36(8):5815–5824. doi:10.1007/s13277-015-3251-3
   PubMedGoogle Scholar
• Guo L, Gao R, Gan J, et al. Downregulation of TNFRSF19 and RAB43 by a novel miRNA, miR-HCC3, promotes proliferation and epithelial-mesenchymal transition in hepatocellular carcinoma cells. Biochem Biophys Res Commun. 2020;525(2):425–432. doi:10.1016/j.bbrc.2020.02.105
   Web of Science ®Google Scholar
• Wang W, Jia WD, Hu B, Pan YY. RAB10 overexpression promotes tumor growth and indicates poor prognosis of hepatocellular carcinoma. Oncotarget. 2017;8(16):26434–26447. doi:10.18632/oncotarget.15507
   PubMedGoogle Scholar
• Pan Y, Liu Z, Feng Z, et al. The overexpression of Rabl3 is associated with pathogenesis and clinicopathologic variables in hepatocellular carcinoma. Tumour Biol. 2017;39(4):1010428317696230. doi:10.1177/1010428317696230
   Google Scholar
• An J, Liu Z, Liang Q, et al. Overexpression of Rabl3 and Cullin7 is associated with pathogenesis and poor prognosis in hepatocellular carcinoma. Hum Pathol. 2017;67:146–151. doi:10.1016/j.humpath.2017.07.008
   Web of Science ®Google Scholar
• Sui Y, Zheng X, Zhao D. Rab31 promoted hepatocellular carcinoma (HCC) progression via inhibition of cell apoptosis induced by PI3K/AKT/Bcl-2/BAX pathway. Tumour Biol. 2015;36(11):8661–8670. doi:10.1007/s13277-015-3626-5
   Google Scholar
• Chua CE, Tang BL. The role of the small GTPase Rab31 in cancer. J Cell Mol Med. 2015;19(1):1–10. doi:10.1111/jcmm.12403
   PubMed Web of Science ®Google Scholar
• Zhang ZY, Lu M, Liu ZK, et al. Rab11a regulates MMP2 expression by activating the PI3K/AKT pathway in human hepatocellular carcinoma cells. Pathol Res Pract. 2020;216(9):153046. doi:10.1016/j.prp.2020.153046
   PubMed Web of Science ®Google Scholar
• Loewith R, Hall MN. Target of rapamycin (TOR) in nutrient signaling and growth control. Genetics. 2011;189(4):1177–1201.
   PubMed Web of Science ®Google Scholar
• Xu BH, Li XX, Yang Y, et al. Aberrant amino acid signaling promotes growth and metastasis of hepatocellular carcinomas through Rab1A-dependent activation of mTORC1 by Rab1A. Oncotarget. 2015;6(25):20813–20828. doi:10.18632/oncotarget.5175
   PubMedGoogle Scholar
• Barbieri MA, Roberts RL, Gumusboga A, et al. Epidermal growth factor and membrane trafficking. EGF receptor activation of endocytosis requires Rab5a. J Cell Biol. 2000;151(3):539–550. doi:10.1083/jcb.151.3.539
   PubMed Web of Science ®Google Scholar
• Geng D, Zhao W, Feng Y, Liu J. Overexpression of Rab25 promotes hepatocellular carcinoma cell proliferation and invasion. Tumour Biol. 2016;37:7713–7718. doi:10.1007/s13277-015-4606-5
   Google Scholar
• Shi LW, Zhao ZB, Zhong L, et al. Overexpression of Rab40b promotes hepatocellular carcinoma cell proliferation and metastasis via PI3K/AKT signaling pathway. Cancer Manag Res. 2020;12:10139–10150. doi:10.2147/CMAR.S255870
   Web of Science ®Google Scholar
• Dong WW, Mou Q, Chen J, Cui JT, Li WM, Xiao WH. Differential expression of Rab27A/B correlates with clinical outcome in hepatocellular carcinoma. World J Gastroenterol. 2012;18(15):1806–1813. doi:10.3748/wjg.v18.i15.1806
   Web of Science ®Google Scholar
• Wang T, Hong W. Interorganellar regulation of lysosome positioning by the Golgi apparatus through Rab34 interaction with Rab-interacting lysosomal protein. Mol Biol Cell. 2002;13(12):4317–4332. doi:10.1091/mbc.e02-05-0280
   Web of Science ®Google Scholar
• Wu J, Lu Y, Qin A, Qiao Z, Jiang X. Overexpression of RAB34 correlates with poor prognosis and tumor progression in hepatocellular carcinoma. Oncol Rep. 2017;38:2967–2974. doi:10.3892/or.2017.5957
   Web of Science ®Google Scholar
• Su H, Yang JR, Xu T, et al. MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity. Cancer Res. 2009;69(3):1135–1142. doi:10.1158/0008-5472.CAN-08-2886
   PubMed Web of Science ®Google Scholar
• Sheng Y, Li J, Zou C, et al. Downregulation of miR-101-3p by hepatitis B virus promotes proliferation and migration of hepatocellular carcinoma cells by targeting Rab5a. Arch Virol. 2014;159(9):2397–2410.
   Web of Science ®Google Scholar
• Dong Z, Qi R, Guo X, et al. MiR-223 modulates hepatocellular carcinoma cell proliferation through promoting apoptosis via the Rab1-mediated mTOR activation. Biochem Biophys Res Commun. 2017;483(1):630–637. doi:10.1016/j.bbrc.2016.12.091
   Web of Science ®Google Scholar
• Xu WP, Liu JP, Feng JF, et al. miR-541 potentiates the response of human hepatocellular carcinoma to sorafenib treatment by inhibiting autophagy. Gut. 2019;69:1309–1321.
   PubMed Web of Science ®Google Scholar
• Wang B, Dong W, Li X. miR-145-5p acts as a novel tumor suppressor in hepatocellular carcinoma through targeting RAB18. Technol Cancer Res Treat. 2019;18:1533033819850189. doi:10.1177/1533033819850189
   Web of Science ®Google Scholar
• Xue H, Tian GY. MiR-429 regulates the metastasis and EMT of HCC cells through targeting RAB23. Arch Biochem Biophys. 2018;637:48–55. doi:10.1016/j.abb.2017.11.011
   PubMed Web of Science ®Google Scholar
• Chen Z, Wang X, Liu R, et al. KDM4B-mediated epigenetic silencing of miRNA-615-5p augments RAB24 to facilitate malignancy of hepatoma cells. Oncotarget. 2017;8(11):17712–17725. doi:10.18632/oncotarget.10832
   Google Scholar
• Kong Q, Fan Q, Ma X, Li J, Ma R. CircRNA circUGGT2 contributes to hepatocellular carcinoma development via regulation of the miR-526b-5p/RAB1A axis. Cancer Manag Res. 2020;12:10229–10241. doi:10.2147/CMAR.S263985
   PubMed Web of Science ®Google Scholar
• Yang L, Peng X, Li Y, et al. Long non-coding RNA HOTAIR promotes exosome secretion by regulating RAB35 and SNAP23 in hepatocellular carcinoma. Mol Cancer. 2019;18(1):78. doi:10.1186/s12943-019-0990-6
   PubMed Web of Science ®Google Scholar
• Cao SQ, Zheng H, Sun BC, et al. Long non-coding RNA highly up-regulated in liver cancer promotes exosome secretion. World J Gastroenterol. 2019;25(35):5283–5299. doi:10.3748/wjg.v25.i35.5283
   PubMed Web of Science ®Google Scholar